Acadia Healthcare updated its full-year 2026 guidance to reflect revenue between $3.4 billion and $3.45 billion. Interim Chief Financial Officer David Duckworth also set adjusted EBITDA expectations at $590 million to $615 million, adjusted EPS at $1.45 to $1.60, and operating cash flow at $350 million to $400 million. The company tightened its capital expenditure forecast to a range of $235 million to $255 million and remains on track to add 500 to 600 beds this year. CEO Debra Osteen reiterated confidence in delivering $200 million of incremental adjusted EBITDA versus 2025, while noting that unmodeled supplemental payment approvals in Florida and Ohio could contribute more than $20 million in additional EBITDA.
Acadia Healthcare Company IncCompany issued positive 2026 guidance with revenue, EBITDA, EPS, and cash flow forecasts, and tightened capex.